BCYRN1 and myelodysplastic syndrome: The results indicated that knockdown of BC200 by two BC200 siRNAs inhibited the proliferation of primary bone marrow mononuclear cells (BMMCs) obtained from MDS patients and cultured in vitro (Fig. 1H–J).